| |
|
4. Is neurotoxicity associated with environmental trichloroethylene (TCE)?
Kilburn KH.
Arch Environ Health. 2002 Mar-Apr;57(2):113-20.
Individuals who lived near 2 electronic manufacturing plants were
exposed to odorous chlorinated solvents by inhalation (directly) and by
out gassing from well water. An exposure zone was defined by
concentrations of trichloroethylene, 1,1,1-trichloroethane,
tetrachloroethylene, and vinyl chloride in groundwater. The author
adopted trichloroethylene as a "shorthand" for the exposure
designation. Residents complained of impaired recall and concentration,
and of dizziness; therefore, the focus of this investigation was brain
functions. Neurobehavioral functions, Profile of Mood States,
frequencies of 35 symptoms, and questionnaire responses provided by 236
residents from exposure zones were compared with responses provided by
161 unexposed regional referents and by 67 Phoenix residents who lived
outside the exposure zone areas. Pulmonary functions were measured with
spirometry. Residents of the exposure zones were compared with regional
referents, and the former had significantly (p < .05) delayed simple
and choice reaction times, impaired balance, delayed blink reflex
latency R-1, and abnormal color discrimination. In addition, these
individuals had impaired (1) cognitive functions, (2) attention and perceptual motor speed, and (3) recall. Individuals who lived in
exposure zones had airway obstructions. Adverse mood state scores and
frequencies of 33 of 35 symptoms were elevated. In conclusion,
individuals who lived in the exposure zones had neurobehavioral
impairments, reduced pulmonary functions, elevated Profile of Mood
State scores, and excessive symptom frequencies.
PMID: 12194155
5. Neuropsychological impairment among former microelectronics workers
Bowler RM, Mergler D, Huel G, Harrison R, Cone J.
Neurotoxicology. 1991 Spring;12(1):87-103.
Although chemicals posing potential neurotoxic hazards are commonly
used in the microelectronics industry, there has been no systematic
study of possible chronic nervous system effects in microelectronics
workers. The objective of the present study was to assess
neuropsychological functions of a group of former microelectronics
plant assembly workers and a group of referents, using a matched pair
design. During employment, the former microelectronics workers had been
exposed to multiple organic solvents, including trichloroethylene,
xylene, chlorofluorocarbons and trichloroethane. Referents were
recruited from the same geographic region. From a pool of 180 former
workers and 157 referents, 67 pairs were matched on the basis of age,
sex, ethnicity, educational level, sex and number of children.
Comparison of results on the subtests of the California
Neuropsychological Screening Battery-Revised (CNS-R) revealed
significantly lower performance by the former microelectronics workers
on tests of attention/concentration, verbal ability, memory functions,
visuospatial functions, visuomotor speed, cognitive flexibility,
psychomotor speed, and reaction time (t-test for pairs or Wilcoxon
Signed Rank p less than 0.05). No significant differences were observed
for performance on tests assessing mental status, visual recall,
tactile function and learning. This overall pattern of impairment is
consistent with organic solvent-related chronic toxic encephalopathy,
and possible early stages of dementia. These findings underline the
need for more studies among workers currently or previously employed in
microelectronics industries.
PMID: 2014071
6. Increased subjective symptom prevalence among workers exposed to trichloroethylene at sub-OEL levels
Liu YT et al.
Tohoku J Exp Med. 1988 Jun;155(2):183-95.
http://tinyurl.com/6p8u2l
Over 100 workers exposed to trichloroethylene (TRI) mostly at less than
50 ppm during the production or vapor degreasing operation and about an
equal number of the non-exposed control workers were examined for
subjective symptoms, hematology, serum biochemistry, and sugar, protein
and occult blood in urine. Essentially all the clinico-laboratory tests
stayed normal, and there was no significant differences in the findings
between the exposed and the controls. Thus, no clinically significant
effects of TRI exposure were found in the blood and liver functions
among the exposed workers as compared with the controls. The prevalence
of the subjective symptoms was, however, significantly higher in the
exposed group than in the controls, and dose-response relationship
could be established in some selected symptoms such as nausea, heavy
feeling in the head, forgetfulness, tremor in extremities, cramp in
extremities and dry mouth, although the exposure was low. The findings
warrant further attention to the effects of TRI especially on the
central nervous system at the concentration lower than e.g., 50 ppm.
PMID: 3212780
7. Attention-deficit hyperactivity disorder and blood mercury level: a
case-control study in chinese children
Cheuk DK, Wong V.
Neuropediatrics. 2006 Aug;37(4):234-40.
OBJECTIVE: To investigate the association between blood mercury
level and attention-deficit hyperactivity disorder (ADHD) in Chinese
children in Hong Kong. METHODS: Fifty-two children with ADHD aged below
18 years diagnosed by DSM IV criteria without perinatal brain insults,
mental retardation or neurological deficits were recruited from a
developmental assessment center. Fifty-nine normal controls were
recruited from a nearby hospital. Blood mercury levels were measured by
cold vapor atomic absorption spectrophotometry. RESULTS: The mean ages
of cases and controls were 7.06 and 7.81 years respectively. Boys
predominated (case = 44 [84.6 %], control = 44 [74.6 %]). There was
significant difference in blood mercury levels between cases and
controls (geometric mean 18.2 nmol/L [95 % CI 15.4 - 21.5 nmol/L] vs.
11.6 nmol/L [95 % CI 9.9 - 13.7 nmol/L], p < 0.001), which persists
after adjustment for age, gender and parental occupational status (p
< 0.001). The geometric mean blood mercury level was also
significantly higher in children with inattentive (19.4 nmol/L, 95 % CI
13.3 - 28.5 nmol/L) and combined (18.0 nmol/L, 95 % CI 14.9 - 21.8
nmol/L) subtypes of ADHD. Blood mercury levels were above 29 nmol/L in
17 (26.9 %) cases and 6 (10.2 %) controls. Children with blood mercury
level above 29 nmol/L had 9.69 times (95 % CI 2.57 - 36.5) higher risk
of having ADHD after adjustment for confounding variables. CONCLUSION:
High blood mercury level was associated with ADHD. Whether the
relationship is causal requires further studies.
PMID: 17177150
8. Exposures to Environmental Toxicants and Attention Deficit
Hyperactivity Disorder in U.S. Children
Joe M. Braun et al.
Environ Health Perspect 114:1904–1909 (2006)
http://www.ehponline.org/members/2006/9478/9478.html
Objective: The purpose of this study was to examine the association of
exposures to tobacco smoke and environmental lead with attention
deficit hyperactivity disorder (ADHD) .
Methods: Data were obtained from the National Health and Nutrition
Examination Survey 1999–2002. Prenatal and postnatal tobacco exposure
was based on parent report ; lead exposure was measured using blood
lead concentration. ADHD was defined as having current stimulant
medication use and parent report of ADHD diagnosed by a doctor or
health professional.
Results: Of 4,704 children 4–15 years of age, 4.2% were reported to
have ADHD and stimulant medication use, equivalent to 1.8 million
children in the United States. In multivariable analysis, prenatal
tobacco exposure [odds ratio (OR) = 2.5 ; 95% confidence interval (CI)
, 1.2–5.2] and higher blood lead concentration (first vs. fifth
quintile, OR = 4.1 ; 95% CI, 1.2–14.0) were significantly associated
with ADHD. Postnatal tobacco smoke exposure was not associated with
ADHD (OR = 0.6 ; 95% CI, 0.3–1.3 ; p = 0.22) . If causally linked,
these data suggest that prenatal tobacco exposure accounts for 270,000
excess cases of ADHD, and lead exposure accounts for 290,000 excess
cases of ADHD in U.S. children.
Conclusions: We conclude that exposure to prenatal tobacco and
environmental lead are risk factors for ADHD in U.S. children.
9. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas
Palmer RF et al.
Health Place. 2006 Jun;12(2):203-9.
"On average, for each 1,000 lb of environmentally released mercury,
there was a 43% increase in the rate of special education services and
a 61% increase in the rate of autism. The association between
environmentally released mercury and special education rates were fully
mediated by increased autism rates."
10. Proximity to point sources of environmental mercury release as a predictor of autism prevalence
Palmer RF et al.
Health Place. 2008 Feb 12.
"We found that for every 1000 pounds of industrial release, there was a
corresponding 2.6% increase in autism rates (p<.05) and a 3.7%
increase associated with power plant emissions(P<.05)... For every
10 miles from industrial or power plant sources, there was an
associated decreased autism Incident Risk of 2.0% and 1.4%,
respectively (p<.05)."
11. In-home toxic chemical exposures and children with intellectual and
developmental disabilities
Graff JC, Murphy L, Ekvall S, Gagnon M.
Pediatr Nurs. 2006 Nov-Dec;32(6):596-603.
Despite the focus on preventing toxic chemical exposures during
pregnancy, the perinatal period, and childhood, health professionals
have given little attention to the risks and effects of toxic chemical
exposures on children with intellectual and developmental disabilities
(DD). Children with DD may be at higher risk due to behaviors that
persist past a developmentally appropriate age, communication skills,
motor skills, nutrition issues, and health problems related to DD. This
article examines exposure of children to lead, mercury, and
environmental tobacco smoke, three toxicants known to affect children's
health and development. The authors identify sources of these
toxicants, examine research documenting their effects on children,
consider strategies to prevent and manage exposure, identify
characteristics and behaviors placing children with DD at increased
risk of exposure, and discuss implications for health providers.
PMID: 17256300
12. Exposure to hexachlorobenzene during pregnancy and children's social behavior at 4 years of age
Ribas-Fitó N et al.
Environ Health Perspect. 2007 Mar;115(3):447-50.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17431497
BACKGROUND: Hexachlorobenzene (HCB) is an organochlorine chemical that
has been used in agriculture and industrial processes. Behavioral
impairment after HCB exposure has been described in animal models, but
little information is available in humans. OBJECTIVES: Our goal was to
study the association of prenatal exposure to HCB with the social
behavior of preschool children. METHODS: Two birth cohorts in Ribera
d'Ebre and Menorca (Spain) were set up between 1997 and 1999 (n = 475).
The California Preschool Social Competence Scale and the
Attention-Deficit Hyperactivity Disorder (ADHD) were scored by each
4-year-old child's teacher. Organochlorine compounds were measured in
cord serum. Children's diet and parental sociodemographic information
were obtained through questionnaire. RESULTS: Children with
concentrations of HCB > 1.5 ng/mL at birth had a statistically
significant increased risk of having poor Social Competence [relative
risk (RR) = 4.04; 95% confidence interval (CI), 1.76-9.58] and ADHD (RR
= 2.71; 95% CI, 1.05-6.96) scores. No association was found between HCB
and the cognitive and psychomotor performance of these children.
CONCLUSIONS: Prenatal exposure to current concentrations of HCB in
Spain is associated with a decrease in the behavioral competence at
preschool ages. These results should be considered when evaluating the
potential neurotoxicologic effects of HCB.
PMID: 17431497
13: Indoor organophosphate and polybrominated flame retardants in Tokyo
Saito I, Onuki A, Seto H.
Indoor Air. 2007 Feb;17(1):28-36.
In Japan, organophosphate and polybrominated flame retardants are
used in building materials and electric appliances to protect them from
fire hazards. In this study, to identify the emission sources of these
flame retardants to indoor air, the migration rates (flux) of
organophosphate and polybrominated flame retardants from building
materials and electrical appliances to solid extraction disks that were
placed in contact with the interior surfaces were measured. In addition
to the migration test, indoor air and outdoor air concentrations of
these flame retardants were investigated. With regard to building
materials in a newly built house, triethylphosphate (TEP) and
tributylphosphate (TBP) were detected in the wall and ceiling
coverings, and tris(2-butoxyethyl)phosphate (TBEP) was detected in the
wooden flooring cleaned with a floor polish agent. With regard to
electrical appliances, triphenylphosphate (TPHP) was predominantly
detected in computer monitors and tris(2-chloroethyl) phosphate (TCEP)
in television (TV) sets, with the highest median levels. Among the
polybrominated compounds, only 2,2',4,4'-tetrabromodiphenyl ether
(BDE-47) was detected from a few old TV sets manufactured before 1995.
In an indoor and outdoor air survey, nine organophosphates and nine
polybrominated flame retardants were detected from indoor air. In
outdoor air, only four organophosphate flame retardants were detected.
The maximum level of indoor organophosphate compounds was 1260 ng/m(3)
with tris(2-chloro-1-methylethyl) phosphate (TCPP), and that of
polybrominated compounds was 29.5 ng/m(3) with hexabromocyclododecane
(HBCD). Tetrabromobisphenol A (TBBPA) was not detected in this study,
although it has the largest demand among flame retardants in Japan. The
results of the migration test and the indoor air survey revealed that
in indoor air, organophosphate compounds were more predominant than
polybrominated compounds in Tokyo. PRACTICAL IMPLICATIONS:
Polybrominated biphenyls (PBB) and polybrominated diphenyl ethers
(PBDE) are commonly used as flame retardants in plastics. The use of
these two compounds in electric appliances will be banned in 2007 by
the EU Directives on waste electrical and electronic equipment (WEEE)
and on the restriction of the use of certain hazardous substances
(RoHS) in electrical and electronic equipment. In Japan, the use of PBB
was banned and that of PBDE diminished in the early 1990s by the
self-imposed controls of the Japanese Flame Retardants Conference
(Akutu and Hori, 2004). In Japan, the predominantly used organic flame
retardants were tetrabromobisphenol A and organophosphate compounds.
Tetrabromobisphenol A has been reported to disrupt endocrine systems
(Kitamura et al., 2005), and some organophosphate flame retardants were
recently reported to have neurochemical hazardous effects. Furthermore,
organophosphate compounds were suspected to cause endocrine-disrupting
effects (Fang et al., 2003; Ohyama et al., 2005) or attention deficit
hyperactivity disorder (ADHD) (Winrow et al., 2003). In this study,
organophosphate and polybrominated flame retardants were surveyed in
indoor environments in Tokyo.
PMID: 17257150
14. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children
Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, Barr DB, Whitehead R, Tang D, Whyatt RW.
Pediatrics. 2006 Dec;118(6):e1845-59. Epub 2006 Nov 20.
http://pediatrics.aappublications.org/cgi/content/full/118/6/e1845
OBJECTIVE: The purpose of this study was to investigate the impact of
prenatal exposure to chlorpyrifos on 3-year neurodevelopment and
behavior in a sample of inner-city minority children. METHODS: As part
of an ongoing prospective cohort study in an inner-city minority
population, neurotoxicant effects of prenatal exposure to chlorpyrifos
were evaluated in 254 children through the first 3 years of life. This
report examined cognitive and motor development at 12, 24, and 36
months (measured with the Bayley Scales of Infant Development II) and
child behavior at 36 months (measured with the Child Behavior
Checklist) as a function of chlorpyrifos levels in umbilical cord
plasma. RESULTS: Highly exposed children (chlorpyrifos levels of
>6.17 pg/g plasma) scored, on average, 6.5 points lower on the
Bayley Psychomotor Development Index and 3.3 points lower on the Bayley
Mental Development Index at 3 years of age compared with those with
lower levels of exposure. Children exposed to higher, compared with
lower, chlorpyrifos levels were also significantly more likely to
experience Psychomotor Development Index and Mental Development Index
delays, attention problems, attention-deficit/hyperactivity disorder
problems, and pervasive developmental disorder problems at 3 years of
age. CONCLUSIONS: The adjusted mean 36-month Psychomotor Development
Index and Mental Development Index scores of the highly and lower
exposed groups differed by only 7.1 and 3.0 points, respectively, but
the proportion of delayed children in the high-exposure group, compared
with the low-exposure group, was 5 times greater for the Psychomotor
Development Index and 2.4 times greater for the Mental Development
Index, increasing the number of children possibly needing early
intervention services.
PMID: 17116700
15. Paraoxonase gene variants are associated with autism in North America,
but not in Italy: possible regional specificity in gene-environment
interactions
D'Amelio M et al.
Mol Psychiatry. 2005 Nov;10(11):1006-16.
Organophosphates (OPs) are routinely used as pesticides in agriculture
and as insecticides within the household. Our prior work on Reelin and
APOE delineated a gene-environment interactive model of autism
pathogenesis, whereby genetically vulnerable individuals prenatally
exposed to OPs during critical periods in neurodevelopment could
undergo altered neuronal migration, resulting in an autistic syndrome.
Since household use of OPs is far greater in the USA than in Italy,
this model was predicted to hold validity in North America, but not in
Europe. Here, we indirectly test this hypothesis by assessing
linkage/association between autism and variants of the paraoxonase gene
(PON1) encoding paraoxonase, the enzyme responsible for OP
detoxification. Three functional single nucleotide polymorphisms, PON1
C-108T, L55M, and Q192R, were assessed in 177 Italian and 107
Caucasian-American complete trios with primary autistic probands. As
predicted, Caucasian-American and not Italian families display a
significant association between autism and PON1 variants less active in
vitro on the OP diazinon (R192), according to case-control contrasts
(Q192R: chi2=6.33, 1 df, P<0.025), transmission/disequilibrium tests
(Q192R: TDT chi2=5.26, 1 df, P<0.025), family-based association
tests (Q192R and L55M: FBAT Z=2.291 and 2.435 respectively,
P<0.025), and haplotype-based association tests (L55/R192: HBAT
Z=2.430, P<0.025). These results are consistent with our model and
provide further support for the hypothesis that concurrent genetic
vulnerability and environmental OP exposure may possibly contribute to
autism pathogenesis in a sizable subgroup of North American individuals.
PMID: 16027737
16. Maternal residence near agricultural pesticide applications and autism
spectrum disorders among children in the California Central Valley
Roberts EM et al.
Environ Health Perspect. 2007 Oct;115(10):1482-9.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2022638&blobtype=pdf
BACKGROUND: Ambient levels of pesticides ("pesticide drift") are
detectable at residences near agricultural field sites. OBJECTIVE: Our
goal was to evaluate the hypothesis that maternal residence near
agricultural pesticide applications during key periods of gestation
could be associated with the development of autism spectrum disorders
(ASD) in children. METHODS: We identified 465 children with ASD born
during 1996-1998 using the California Department of Developmental
Services electronic files, and matched them by maternal date of last
menstrual period to 6,975 live-born, normal-birth-weight, term infants
as controls. We determined proximity to pesticide applications using
California Department of Pesticide Regulation records refined using
Department of Water Resources land use polygons. A staged analytic
design applying a priori criteria to the results of conditional
logistic regressions was employed to exclude associations likely due to
multiple testing error. RESULTS: Of 249 unique hypotheses, four that
described organochlorine pesticide applications--specifically those of
dicofol and endosulfan--occurring during the period immediately before
and concurrent with central nervous system embryogenesis (clinical
weeks 1 through 8) met a priori criteria and were unlikely to be a
result of multiple testing. Multivariate a posteriori models comparing
children of mothers living within 500 m of field sites with the highest
nonzero quartile of organochlorine poundage to those with mothers not
living near field sites suggested an odds ratio for ASD of 6.1 (95%
confidence interval, 2.4-15.3). ASD risk increased with the poundage of
organochlorine applied and decreased with distance from field sites.
CONCLUSIONS: The association between residential proximity to
organochlorine pesticide applications during gestation and ASD among
children should be further studied.
PMID: 17938740
17. Guidelines for developmental neurotoxicity and their impact on
organophosphate pesticides: a personal view from an academic
perspective
Slotkin TA.
Neurotoxicology. 2004 Jun;25(4):631-40.
The appropriate regulation of drugs, chemicals and environmental
contaminants requires the establishment of clear and accepted
guidelines for developmental neurotoxicity. Ideally, these guidelines
should encompass the ability to assess widely disparate classes of
compounds through routine tests, with high throughput and low cost.
Increasingly, however, the progress in primary research from academic
laboratories deviates from this goal, focusing instead on categorizing
novel effects of toxicants, development of new testing paradigms, and
extension of techniques into molecular biology. The differing
objectives of academic science as opposed to those of regulatory
agencies or industry, are driven in part, by the priorities of the
agencies that fund primary research. Recent work on organophosphate
pesticides (OPs) such as chlorpyrifos (CPF) illustrate this dichotomy.
Originally, OPs were thought to affect brain development through their
ability to elicit cholinesterase inhibition and consequent cholinergic
hyperstimulation. This common mechanism allowed for parallels to be
drawn between standard measures of systemic toxicity, gross
morphological examinations, and exposure testing utilizing an
easily-assessed surrogate endpoint, plasma cholinesterase activity. In
the past decade, however, it has become increasingly evident that CPF,
and probably other OPs, have direct effects on cellular processes that
are unique to brain development, and that these effects are
mechanistically unrelated to inhibition of cholinesterase. The
identification and pursuit of these mechanisms and their consequences
for brain development represent new and exciting scientific findings,
while at the same obscuring the ability to sustain a uniform approach
to neurotoxicity guidelines or biomarkers of exposure. In the future, a
new set of test paradigms, relying on primary work in cell culture,
invertebrates, or non-mammalian models, followed by more targeted
examinations of specific processes in mammalian models, may unite
cutting-edge academic research with the need for establishing flexible
guidelines for developmental neurotoxicity.
PMID: 15183016
18. Are we on the threshold of a new theory of disease? Toxicant-induced
loss of tolerance and its relationship to addiction and abdiction
Miller CS.
Toxicol Ind Health. 1999 Apr-Jun;15(3-4):284-94.
'Toxicant-induced loss of tolerance' (or TILT) describes a two-step
disease process in which (1) certain chemical exposures, e.g., indoor
air contaminants, chemical spills, or pesticide applications, cause
certain susceptible persons to lose their prior natural tolerance for
common chemicals, foods, and drugs (initiation); (2) subsequently,
previously tolerated exposures trigger symptoms. Responses may manifest
as addictive or abdictive (avoidant) behaviors. In some affected
individuals, overlapping responses to common chemical, food, and drug
exposures, as well as habituation to recurrent exposures, may hide
(mask) responses to particular triggers. Accumulating evidence suggests
that this disease process might underlie a broad array of medical
illnesses including chronic fatigue, fibromyalgia, migraine headaches,
depression, asthma, the unexplained illnesses of Gulf War veterans,
multiple chemical sensitivity, and attention deficit disorder.
PMID: 10416280
19. Profile of patients with chemical injury and sensitivity
Ziem G, McTamney J.
Environ Health Perspect. 1997 Mar;105 Suppl 2:417-36.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1469804&blobtype=pdf
Patients reporting sensitivity to multiple chemicals at levels usually
tolerated by the healthy population were administered standardized
questionnaires to evaluate their symptoms and the exposures that
aggravated these symptoms. Many patients were referred for medical
tests. It is thought that patients with chemical sensitivity have organ
abnormalities involving the liver, nervous system (brain, including
limbic, peripheral, autonomic), immune system, and porphyrin
metabolism, probably reflecting chemical injury to these systems.
Laboratory results are not consistent with a psychologic origin of
chemical sensitivity. Substantial overlap between chemical sensitivity,
fibromyalgia, and chronic fatigue syndrome exists: the latter two
conditions often involve chemical sensitivity and may even be the same
disorder. Other disorders commonly seen in chemical sensitivity
patients include headache (often migraine), chronic fatigue,
musculoskeletal aching, chronic respiratory inflammation (rhinitis,
sinusitis, laryngitis, asthma), attention deficit, and hyperactivity
(affected younger children). Less common disorders include tremor,
seizures, and mitral valve prolapse. Patients with these overlapping
disorders should be evaluated for chemical sensitivity and excluded
from control groups in future research. Agents whose exposures are
associated with symptoms and suspected of causing onset of chemical
sensitivity with chronic illness include gasoline, kerosene, natural
gas, pesticides (especially chlordane and chlorpyrifos), solvents, new
carpet and other renovation materials, adhesives/glues, fiberglass,
carbonless copy paper, fabric softener, formaldehyde and
glutaraldehyde, carpet shampoos (lauryl sulfate) and other cleaning
agents, isocyanates, combustion products (poorly vented gas heaters,
overheated batteries), and medications (dinitrochlorobenzene for warts,
intranasally packed neosynephrine, prolonged antibiotics, and general
anesthesia with petrochemicals). Multiple mechanisms of chemical injury
that magnify response to exposures in chemically sensitive patients can
include neurogenic inflammation (respiratory, gastrointestinal,
genitourinary), kindling and time-dependent sensitization (neurologic),
impaired porphyrin metabolism (multiple organs), and immune activation.
PMID: 9167975
20. Environmental evaluation of a child with developmental disability
Hussain J, Woolf AD, Sandel M, Shannon MW.
Pediatr Clin North Am. 2007 Feb;54(1):47-62, viii.
Children's health can be affected adversely by the environment in which
they live. It is well recognized that some environmental chemicals are
harmful to the brain, but the role these chemicals play in the
development of specific disabilities such as attention deficit
hyperactivity disorder and autism is not certain. Parents of children
who have developmental disabilities often ask the primary care
physician whether certain environmental toxicants might be the cause of
the illness. A detailed environmental history and physical examination
may help clarify whether there is a plausible relationship between an
environmental toxicant and a child's disability.
PMID: 17306683
21. Developmental neurotoxicity of industrial chemicals
Grandjean P, Landrigan PJ.
Lancet. 2006 Dec 16;368(9553):2167-78.
Neurodevelopmental disorders such as autism, attention deficit
disorder, mental retardation, and cerebral palsy are common, costly,
and can cause lifelong disability. Their causes are mostly unknown. A
few industrial chemicals (eg, lead, methylmercury, polychlorinated
biphenyls [PCBs], arsenic, and toluene) are recognised causes of
neurodevelopmental disorders and subclinical brain dysfunction.
Exposure to these chemicals during early fetal development can cause
brain injury at doses much lower than those affecting adult brain
function. Recognition of these risks has led to evidence-based
programmes of prevention, such as elimination of lead additives in
petrol. Although these prevention campaigns are highly successful, most
were initiated only after substantial delays. Another 200 chemicals are
known to cause clinical neurotoxic effects in adults. Despite an
absence of systematic testing, many additional chemicals have been
shown to be neurotoxic in laboratory models. The toxic effects of such
chemicals in the developing human brain are not known and they are not
regulated to protect children. The two main impediments to prevention
of neurodevelopmental deficits of chemical origin are the great gaps in
testing chemicals for developmental neurotoxicity and the high level of
proof required for regulation. New, precautionary approaches that
recognise the unique vulnerability of the developing brain are needed
for testing and control of chemicals.
PMID: 17174709
22. The toxicology of mercury and its chemical compounds
Clarkson TW, Magos L.
Crit Rev Toxicol. 2006 Sep;36(8):609-62.
This review covers the toxicology of mercury and its compounds.
Special attention is paid to those forms of mercury of current public
health concern. Human exposure to the vapor of metallic mercury dates
back to antiquity but continues today in occupational settings and from
dental amalgam. Health risks from methylmercury in edible tissues of
fish have been the subject of several large epidemiological
investigations and continue to be the subject of intense debate.
Ethylmercury in the form of a preservative, thimerosal, added to
certain vaccines, is the most recent form of mercury that has become a
public health concern. The review leads to general discussion of
evolutionary aspects of mercury, protective and toxic mechanisms, and
ends on a note that mercury is still an "element of mystery."
PMID: 16973445
23. Impact of prenatal methylmercury exposure on neurobehavioral
function at age 14 years
Debes F et al.
Neurotoxicol Teratol. 2006 Sep-Oct;28(5):536-47.
A cohort of 1022 consecutive singleton births was generated during
1987-1988 in the Faroe Islands, where increased methylmercury exposure
occurs from traditional seafood diets that include pilot whale meat.
The prenatal exposure level was determined from mercury analyses of
cord blood, cord tissue, and maternal hair. At age 14 years, 878 of
1010 living cohort members underwent detailed neurobehavioral
examination. Eighteen participants with neurological disorders were
excluded. Blood and hair samples obtained from the participants were
analyzed for mercury. The neuropsychological test battery was designed
based on the same criteria as applied at the examination at age 7
years. Multiple regression analysis was carried out and included
adjustment for confounders. Indicators of prenatal methylmercury
exposure were significantly associated with deficits in finger tapping
speed, reaction time on a continued performance task, and cued naming.
Postnatal methylmercury exposure had no discernible effect. These
findings are similar to those obtained at age 7 years, and the relative
contribution of mercury exposure to the predictive power of the
multiple regression models was also similar. An analysis of the test
score difference between results at 7 and 14 years suggested that
mercury-associated deficits had not changed between the two
examinations. In structural equation model analyses, the
neuropsychological tests were separated into five groups; methylmercury
exposure was significantly associated with deficits in motor, attention, and verbal tests. These findings are supported by
independent assessment of neurophysiological outcomes. The effects on
brain function associated with prenatal methylmercury exposure
therefore appear to be multi-focal and permanent.
PMID: 16647838
24. Metal concentrations in hair and cognitive assessment in an
adolescent population
Torrente M, Colomina MT, Domingo JL.
Biol Trace Elem Res. 2005 Jun;104(3):215-21.
The objective of this study was to establish the potential
relationship between the levels of various metals in hair and cognitive
functions in children living in zones of Tarragona (Catalonia, Spain)
with different metal pollution levels. Thirty-nine boys and 61 girls
(12-14 yr old) from various schools were selected for the study. The
concentrations of cadmium (Cd), chromium (Cr), mercury (Hg), lead (Pb),
manganese (Mn), nickel (Ni), and tin (Sn) in scalp hair were determined
by inductively coupled plasma- mass spectrometry (ICP-MS). Attention,
visuospatial capabilities, and abstract reasoning were assessed as
indicators of cognitive impairment. Three categories of attention were
defined: low, medium, and high. A significant negative correlation
(p=0.019) between Pb levels in hair and attention was observed.
Significant differences between Pb levels in hair in low- and
medium-performance groups and those in the high-performance group were
also found. Moreover, a positive correlation (p=0.048) between Hg hair
concentrations and visuospatial capabilities was also noted.
PMID: 15930591
25. Mercury exposure in children: a review
Counter SA, Buchanan LH.
Toxicol Appl Pharmacol. 2004 Jul 15;198(2):209-30.
Exposure to toxic mercury (Hg) is a growing health hazard
throughout the world today. Recent studies show that mercury exposure
may occur in the environment, and increasingly in occupational and
domestic settings. Children are particularly vulnerable to Hg
intoxication, which may lead to impairment of the developing central
nervous system, as well as pulmonary and nephrotic damage. Several
sources of toxic Hg exposure in children have been reported in
biomedical literature: (1) methylmercury, the most widespread source of
Hg exposure, is most commonly the result of consumption of contaminated
foods, primarily fish; (2) ethylmercury, which has been the subject of
recent scientific inquiry in relation to the controversial pediatric
vaccine preservative thimerosal; (3) elemental Hg vapor exposure
through accidents and occupational and ritualistic practices; (4)
inorganic Hg through the use of topical Hg-based skin creams and in
infant teething powders; (5) metallic Hg in dental amalgams, which
release Hg vapors, and Hg2+ in tissues. This review examines recent
epidemiological studies of methylmercury exposure in children. Reports
of elemental Hg vapor exposure in children through accidents and
occupational practices, and the more recent observations of the
increasing use of elemental Hg for magico-religious purposes in urban
communities are also discussed. Studies of inorganic Hg exposure from
the widespread use of topical beauty creams and teething powders, and
fetal/neonatal Hg exposure from maternal dental amalgam fillings are
reviewed. Considerable attention was given in this review to pediatric
methylmercury exposure and neurodevelopment because it is the most
thoroughly investigated Hg species. Each source of Hg exposure is
reviewed in relation to specific pediatric health effects, particularly
subtle neurodevelopmental disorders.
PMID: 15236954
26. Low level methylmercury exposure affects neuropsychological
function in adults
Yokoo EM, Valente JG, Grattan L, Schmidt SL, Platt I, Silbergeld EK.
Environ Health. 2003 Jun 4;2(1):8.
BACKGROUND: The neurotoxic effects of methylmercury (MeHg) have
been demonstrated in both human and animal studies. Both adult and
fetal brains are susceptible to the effects of MeHg toxicity. However,
the specific effects of adult exposures have been less well-documented
than those of children with prenatal exposures. This is largely because
few studies of MeHg exposures in adults have used sensitive
neurological endpoints. The present study reports on the results of
neuropsychological testing and hair mercury concentrations in adults
(>17 yrs) living in fishing communities of Baixada Cuiabana (Mato
Grosso) in the Pantanal region of Brazil. METHODS: A cross-sectional
study was conducted in six villages on the Cuiaba River. Participants
included 129 men and women older than 17 years of age. They were
randomly selected in proportion to the age range and number of
inhabitants in each village. Questionnaire information was collected on
demographic variables, including education, occupation, and residence
history. Mercury exposure was determined by analysis of hair using
flameless atomic absorption spectrophotometry. The neurocognitive
screening battery included tests from the Wechsler Memory Scale and the
Wechsler Adult Intelligence Scale, Concentrated Attention Test of the
Toulouse-Pierron Factorial Battery, the Manual Ability Subtests of the
Tests of Mechanical Ability, and the Profile of Mood States. RESULTS:
Mercury exposures in this population were associated with fish
consumption. The hair mercury concentration in the 129 subjects ranged
from 0.56 to 13.6 microg/g; the mean concentration was 4.2 +/- 2.4
micrograms/g and the median was 3.7 microg/g. Hair mercury levels were
associated with detectable alterations in performance on tests of fine
motor speed and dexterity, and concentration. Some aspects of verbal
learning and memory were also disrupted by mercury exposure. The
magnitude of the effects increased with hair mercury concentration,
consistent with a dose-dependent effect. CONCLUSIONS: This study
suggests that adults exposed to MeHg may be at risk for deficits in
neurocognitive function. The functions disrupted in adults, namely
attention, fine-motor function and verbal memory, are similar to some
of those previously reported in children with prenatal exposures.
PMID: 12844364
27. Brain sites of movement disorder: genetic and environmental agents
in neurodevelopmental perturbations
Palomo T, Beninger RJ, Kostrzewa RM, Archer T.
Neurotox Res. 2003;5(1-2):1-26.
In assessing and assimilating the neurodevelopmental basis of the
so-called movement disorders it is probably useful to establish certain
concepts that will modulate both the variation and selection of
affliction, mechanisms-processes and diversity of disease states. Both
genetic, developmental and degenerative aberrations are to be
encompassed within such an approach, as well as all deviations from the
necessary components of behaviour that are generally understood to
incorporate "normal" functioning. In the present treatise, both
conditions of hyperactivity/hypoactivity, akinesia and bradykinesia
together with a constellation of other symptoms and syndromes are
considered in conjunction with the neuropharmacological and brain
morphological alterations that may or may not accompany them, e.g.
following neonatal denervation. As a case in point, the neuroanatomical
and neurochemical points of interaction in Attention Deficit and
Hyperactivity disorder (ADHD) are examined with reference to both the
perinatal metallic and organic environment and genetic backgrounds. The
role of apoptosis, as opposed to necrosis, in cell death during brain
development necessitates careful considerations of the current
explosion of evidence for brain nerve growth factors, neurotrophins and
cytokines, and the processes regulating their appearance, release and
fate. Some of these processes may possess putative inherited
characteristics, like alpha-synuclein, others may to greater or lesser
extents be endogenous or semi-endogenous (in food), like the
tetrahydroisoquinolines, others exogenous until inhaled or injested
through environmental accident, like heavy metals, e.g. mercury.
Another central concept of neurodevelopment is cellular plasticity,
thereby underlining the essential involvement of glutamate systems and
N-methyl-D-aspartate receptor configurations. Finally, an essential
assimilation of brain development in disease must delineate the
relative merits of inherited as opposed to environmental risks not only
for the commonly-regarded movement disorders, like Parkinson's disease,
Huntington's disease and epilepsy, but also for afflictions bearing
strong elements of psychosocial tragedy, like ADHD, autism and
Savantism.
PMID: 12832221
28. Environmental factors associated with a spectrum of
neurodevelopmental deficits
Mendola P, Selevan SG, Gutter S, Rice D.
Ment Retard Dev Disabil Res Rev. 2002;8(3):188-97.
A number of environmental agents have been shown to demonstrate
neurotoxic effects either in human or laboratory animal studies.
Critical windows of vulnerability to the effects of these agents occur
both pre- and postnatally. The nervous system is relatively unique in
that different parts are responsible for different functional domains,
and these develop at different times (e.g., motor control, sensory,
intelligence and attention). In addition, the many cell types in the
brain have different windows of vulnerability with varying
sensitivities to environmental agents. This review focuses on two
environmental agents, lead and methylmercury, to illustrate the
neurobehavioral and cognitive effects that can result from early life
exposures. Special attention is paid to distinguishing between the
effects detected following episodes of poisoning and those detected
following lower dose exposures. Perinatal and childhood exposure to
high doses of lead results in encephalopathy and convulsions.
Lower-dose lead exposures have been associated with impairment in
intellectual function and attention. At high levels of prenatal
exposure, methylmercury produces mental retardation, cerebral palsy and visual and auditory deficits in children of exposed mothers. At lower
levels of methylmercury exposure, the effects in children have been
more subtle. Other environmental neurotoxicants that have been shown to
produce developmental neurotoxicity include polychlorinated biphenyls
(PCBs), dioxins, pesticides, ionizing radiation, environmental tobacco
smoke, and maternal use of alcohol, tobacco, marijuana and cocaine.
Exposure to environmental agents with neurotoxic effects can result in
a spectrum of adverse outcomes from severe mental retardation and
disability to more subtle changes in function depending on the timing
and dose of the chemical agent. Copyright 2002 Wiley-Liss, Inc.
PMID: 12216063
29. The role of mercury in the pathogenesis of autism
Bernard S, Enayati A, Roger H, Binstock T, Redwood L.
Mol Psychiatry. 2002;7 Suppl 2:S42-3.
http://www.nature.com/mp/journal/v7/n2s/pdf/4001177a.pdf
PMID: 12142947
30. A meta-analysis for neurobehavioural results due to occupational
mercury exposure
Meyer-Baron M, Schaeper M, Seeber A.
Arch Toxicol. 2002 Apr;76(3):127-36.
A meta-analysis for neurobehavioural test results of subjects
occupationally exposed to mercury was carried out in order to find
general tendencies and express possible deficits numerically. Out of 44
studies investigating neurobehavioural functions of occupationally
exposed individuals, 12 studies provided the data required and were
included in the analysis. In all, 14 neuropsychological tests with 20
different tasks were analysed. The results related to 686 exposed and
579 control subjects. Nine significant performance effects were shown
for mean urinary concentrations between 18 and 34 microg Hg/g
creatinine. The effects sizes (D(W+)) referred to attention (D(W+)=-0.40 and -0.46), memory (D(W+)=-0.38 and -0.40), construction
(D(W+)=-0.20) and motor performance (D(W+)=-0.24, -0.40, -0.44 and
-0.47). Additionally there was evidence for a dose-response
relationship of effect sizes, if all test results were taken into
account. Whether the effect sizes could be subject to overestimation
was discussed, but there were no reasons for such an assumption. The
results can be used as suggestions for new discussions about threshold
limit values.
PMID: 11967617
31. In harm's way: toxic threats to child development
Stein J et al.
J Dev Behav Pediatr. 2002 Feb;23(1 Suppl):S13-22.
Developmental disabilities result from complex interactions of
genetic, toxicologic (chemical), and social factors. Among these
various causes, toxicologic exposures deserve special scrutiny because
they are readily preventable. This article provides an introduction to
some of the literature addressing the effects of these toxicologic
exposures on the developing brain. This body of research demonstrates
cause for serious concern that commonly encountered household and
environmental chemicals contribute to developmental disabilities. The
developing brain is uniquely susceptible to permanent impairment by
exposure to environmental substances during time windows of
vulnerability. Lead, mercury, and polychlorinated biphenyls (PCBs) have
been extensively studied and found to impair development at levels of
exposure currently experienced by significant portions of the general
population. High-dose exposures to each of these chemicals cause
catastrophic developmental effects. More recent research has revealed
toxicity at progressively lower exposures, illustrating a "declining
threshold of harm" commonly observed with improved understanding of
developmental toxicants. For lead, mercury, and PCBs, recent studies
reveal that background-population exposures contribute to a wide
variety of problems, including impairments in attention, memory,
learning, social behavior, and IQ. Unfortunately, for most chemicals
there is little data with which to evaluate potential risks to
neurodevelopment. Among the 3000 chemicals produced in highest volume
(over 1 million lbs/yr), only 12 have been adequately tested for their
effects on the developing brain. This is a matter of concern because
the fetus and child are exposed to untold numbers, quantities, and
combinations of substances whose safety has not been established. Child
development can be better protected by more precautionary regulation of
household and environmental chemicals. Meanwhile, health care providers
and parents can play an important role in reducing exposures to a wide
variety of known and suspected neurodevelopmental toxicants that are
widely present in consumer products, food, the home, and wider
community.
PMID: 11875286
32. Toxic threats to neurologic development of children
Schettler T.
Environ Health Perspect. 2001 Dec;109 Suppl 6:813-6.
http://www.ehponline.org/members/2001/suppl-6/813-816schettler/schettler-full.html
Learning disabilities, attention deficit hyperactivity disorder,
developmental delays, and emotional and behavioral problems are among
childhood disabilities of increasing concern. Interacting genetic,
environmental, and social factors are important determinants of
childhood brain development and function. For many reasons, however,
studying neurodevelopmental vulnerabilities in children is challenging.
Moreover, inadequate incidence and trend data interfere with full
understanding of the magnitude of the problem. Despite these
difficulties, extensive laboratory and clinical studies of several
neurodevelopmental toxicants, including lead, mercury, polychlorinated
biphenyls, alcohol, and nicotine, demonstrate the unique vulnerability
of the developing brain to environmental agents at exposure levels that
have no lasting effect in adults. Historically, understanding the
effects of these toxicants on the developing brain has emerged slowly
while generations of children are exposed to unsafe levels.
Unfortunately, with few exceptions, neurodevelopmental toxicity data
are missing for most industrial chemicals in widespread use, even when
populationwide exposures are documented. The personal, family, and
communitywide costs of developmental disabilities are profound. In
addition to the need for more research, a preventive public health
response requires mitigation of exposures to potential
neurodevelopmental toxicants when available evidence establishes the
plausibility of harm, despite residual toxicologic uncertainties.
PMID: 11744499
33. Effects of metals on the nervous system of humans and animals
Carpenter DO.
Int J Occup Med Environ Health. 2001;14(3):209-18.
Several metals have toxic actions on nerve cells and
neurobehavorial functioning. These toxic actions can be expressed
either as developmental effects or as an increased risk of
neurodegenerative diseases in old age. The major metals causing
neurobehavioral effects after developmental exposure are lead and
methylmercury. Lead exposure in young children results in a permanent
loss of IQ of approximately 5 to 7 IQ points, and also results in a
shortened attention span and expression of anti-social behaviors. There
is a critical time period (<2 years of age) for development of these
effects, after which the effects do not appear to be reversible even if
blood lead levels are lowered with chelation. Methylmercury has also
been found to have effects on cognition at low doses, and prenatal
exposure at higher levels can disrupt brain development. Metals have
also been implicated in neurodegenerative diseases, although it is
unlikely that they are the sole cause for any of them. Elevated
aluminum levels in blood, usually resulting from kidney dialysis at
home with well water containing high aluminum, result in dementia that
is similar to but probably different from that of Alzheimer's disease.
However, there is some epidemiological evidence for elevated risk of
Alzheimer's in areas where there is high concentration of aluminum in
drinking water. Other metals, especially lead, mercury, manganese and
copper, have been implicated in amvotrophic lateral sclerosis and
Parkinson's disease.
PMID: 11764847
34. Vaccines without thiomersal: why so necessary, why so long coming?
van't Veen AJ.
Drugs. 2001;61(5):565-72.
The inorganic mercurial thiomersal (merthiolate) has been used as
an effective preservative in numerous medical and non-medical products
since the early 1930s. Both the potential toxicity of thiomersal and
sensitisation to thiomersal in relation to the application of
thiomersal-containing vaccines and immunoglobulins, especially in
children, have been debated in the literature. The very low thiomersal
concentrations [sic] in pharmacological and biological products are
relatively non-toxic, but probably not in utero and during the first 6
months of life. The developing brain of the fetus is most susceptible
to thiomersal and, therefore, women of childbearing age, in particular,
should not receive thiomersal-containing products. Definitive data of
doses at which developmental effects occur are not available. Moreover,
revelation of subtle effects of toxicity needs long term observation of
children. The ethylmercury radical of the thiomersal molecule appears
to be the prominent sensitiser. The prevalence of thiomersal
hypersensitivity in mostly selected populations varies up to 18%, but
higher figures have been reported. The overall exposure to thiomersal
differs considerably between countries. In many cases a positive
routine patch test to thiomersal should be considered an accidental
finding without or, probably more accurately, with low clinical
relevance. In practice, some preventive measures can be taken with
respect to thiomersal hypersensitivity. However, with regard to the
debate on primary sensitisation during childhood and renewed attention
for a reduction of children's exposure to mercury from all sources, the
use of thiomersal should preferably be eliminated or at least be
reduced. In 1999 the manufacturers of vaccines and immunoglobulins in
the US and Europe were approached with this in mind. The potential
toxicity in children seems to be of much more concern to them than the
hidden sensitising properties of thiomersal. In The Netherlands, unlike
many other countries, the exposure to thiomersal from pharmaceutical
sources has already been reduced. Replacement of thiomersal in all
products should have a high priority in all countries.
PMID: 11368282
35. A two-phased population epidemiological study of the safety of
thimerosal-containing vaccines: a follow-up analysis
Geier DA, Geier MR.
Med Sci Monit. 2005 Apr;11(4):CR160-70. Epub 2005 Mar 24.
BACKGROUND: Thimerosal is an ethylmercury-containing preservative
in vaccines. Toxicokinetic studies have shown children received doses
of mercury from thimerosal-containing vaccines (TCVs) that were in
excess of safety guidelines. Previously, an ecological study showing a
significant association between TCVs and neurodevelopmental disorders
(NDs) in the US was published in this journal. MATERIAL/METHODS: A two
phased population-based epidemiological study was undertaken. Phase one
evaluated reported NDs to the Vaccine Adverse Event Reporting System
(VAERS) following thimerosal-containing
Diphtheria-Tetanus-acellular-Pertussis (DTaP) vaccines in comparison to
thimerosal-free DTaP vaccines administered from 1997 through 2001.
Phase two evaluated the automated Vaccine Safety Datalink (VSD) for
cumulative exposures to mercury from TCVs at 1-, 2-, 3-, and
6-months-of-age for infants born from 1992 through 1997 and the
eventual risk of developing NDs. RESULTS: Phase one showed
significantly increased risks for autism, speech disorders, mental
retardation, personality disorders, and thinking abnormalities reported
to VAERS following thimerosal-containing DTaP vaccines in comparison to
thimerosal-free DTaP vaccines. Phase two showed significant
associations between cumulative exposures to thimerosal and the
following types of NDs: unspecified developmental delay, tics, attention deficit disorder (ADD), language delay, speech delay, and
neurodevelopmental delays in general. CONCLUSIONS: This study showed
that exposure to mercury from TCVs administered in the US was a
consistent significant risk factor for the development of NDs. It is
clear from these data and other recent publications linking TCVs with
NDs that additional ND research should be undertaken in the context of
evaluating mercury-associated exposures and thimerosal-free vaccines
should be made available.
PMID: 15795695
36. Thimerosal exposure in infants and neurodevelopmental disorders: An
assessment of computerized medical records in the Vaccine Safety
Datalink
Young HA et al.
J Neurol Sci. 2008 May 14. [Epub ahead of print]
The study evaluated possible associations between neurodevelopmental
disorders (NDs) and exposure to mercury (Hg) from Thimerosal-containing
vaccines (TCVs) by examining the automated Vaccine Safety Datalink
(VSD). A total of 278,624 subjects were identified in birth cohorts
from 1990-1996 that had received their first oral polio vaccination by
3 months of age in the VSD. The birth cohort prevalence rate of
medically diagnosed International Classification of Disease, 9th
revision (ICD-9) specific NDs and control outcomes were calculated.
Exposures to Hg from TCVs were calculated by birth cohort for specific
exposure windows from birth-7 months and birth-13 months of age.
Poisson regression analysis was used to model the association between
the prevalence of outcomes and Hg doses from TCVs. Consistent
significantly increased rate ratios were observed for autism, autism
spectrum disorders, tics, attention deficit disorder, and emotional
disturbances with Hg exposure from TCVs. By contrast, none of the
control outcomes had significantly increased rate ratios with Hg
exposure from TCVs. Routine childhood vaccination should be continued
to help reduce the morbidity and mortality associated with infectious
diseases, but efforts should be undertaken to remove Hg from vaccines.
Additional studies should be conducted to further evaluate the
relationship between Hg exposure and NDs.
PMID: 18482737
37. Neuropsychological effects associated with exposure to mercury
vapor among former chloralkali workers
Mathiesen T, Ellingsen DG, Kjuus H.
Scand J Work Environ Health. 1999 Aug;25(4):342-50.
OBJECTIVES: This investigation studied possible neuropsychological
effects among former chloralkali workers with past exposure to mercury
vapor. METHODS: Seventy-five formerly exposed workers who had been
examined with an extensive neuropsychological test battery were
compared with 52 referents frequency-matched for age. The tests
measured general cognitive function, motor and psychomotor function,
attention, memory, and learning. The groups were similar in educational
level, age, and verbal comprehension. The mean exposure time to mercury
vapor in the index group was 7.9 (range 1.1-36.2) years with an annual
mean urinary mercury concentration of 539 (range 41-2921) nmol/(l x
year). The mean time since the cessation of exposure was 12.7 (range
1.0-35.0) years. RESULTS: Performance on the grooved pegboard (dominant
hand 75.8 versus 70.9 seconds, P<0.05; nondominant hand 82.2 versus
76.3 seconds, P=0.02) and the Benton visual retention test (mean number
of correct reproductions 6.9 versus 7.5, P<0.05) was poorer among
the formerly exposed workers when compared with the referents. In
addition the subjects who had experienced the highest intensity of
exposure [cumulative urinary mercury index > or =550 nmol/(l x
year)] had a poorer performance on the trailmaking test, part A and B,
on the digit symbol test, and on the word pairs test (retention
errors). CONCLUSIONS: The presented results suggest a slight persistent
effect of mercury vapor exposure on the central nervous system, mainly
involving motor functions and attention, but also possibly related to
the visual system. Previous exposure does not seem to have affected the
workers' general intellectual level or their ability to reason
logically.
PMID: 10505660
38. Methylmercury exposure biomarkers as indicators of neurotoxicity in
children aged 7 years
Grandjean P, Budtz-Jørgensen E, White RF, Jørgensen PJ, Weihe P,
Debes F, Keiding N.
Am J Epidemiol. 1999 Aug 1;150(3):301-5.
The mercury concentration in blood or scalp hair has been widely
used as a biomarker for methylmercury exposure. Because of the
increased risks associated with exposures during prenatal and early
postnatal development, biomarker results must be interpreted with
regard to the age-dependent susceptibility. The authors compared
regression coefficients for five sets of exposure biomarkers in 917
children from the Faroe Islands examined at birth, 1 year, and 7 years.
Outcome variables were the results of neuropsychologic examination
carried out in 1993-1994 at age 7 years. After adjustment for
covariates, the cord-blood concentration showed the clearest
associations with deficits in language, attention, and memory.
Fine-motor function deficits were particularly associated with the
maternal hair mercury at parturition. Mercury concentrations in the
child's blood and hair at age 7 years were significant predictors only
of performance on memory for visuospatial information. These findings
emphasize the usefulness of the cord-blood mercury concentration as a
main risk indicator. They also support the notion that the greatest
susceptibility to methylmercury neurotoxicity occurs during late
gestation, while early postnatal vulnerability is less, and they
suggest that the time-dependent susceptibility may vary for different
brain functions.
PMID: 10430235
39. Chronic elemental mercury intoxication: neuropsychological
follow-up case study
Hua MS, Huang CC, Yang YJ.
Brain Inj. 1996 May;10(5):377-84.
In initial and follow-up investigations of neuropsychological
function in a patient with elemental mercury intoxication, his scores
were compared with those of a group of normal control subjects matched
for sex, age and education. Each subject received a comprehensive
neuropsychological examination including a personality inventory. On
the initial examination the results indicated that the patient had a
significant depression of performance intellectual functioning,
impairments of attention, non-verbal short-term memory and visual
judgement of angles and directions, psychomotor retardation and
personality changes including depression, anxiety, desire to be alone,
lack of interest and sensitivity to physical problems. Such an
impairment picture is compatible with the previous observations of
individuals with chronic exposure to elemental, organic or inorganic
mercury. The follow-up study was undertaken about 1.5 years later. The
results show that the patient's cognitive and personality functions
were fully recovered. Our findings thus suggest a reversibility of
impaired neuropsychological function in persons with elemental mercury
poisoning if a prompt removal from the toxic environment is
accomplished, together with proper medical treatment.
PMID: 8735667
40. Psychological effects of low exposure to mercury vapor: application
of a computer-administered neurobehavioral evaluation system
Liang YX, Sun RK, Sun Y, Chen ZQ, Li LH.
Environ Res. 1993 Feb;60(2):320-7.
A computer-administered neurobehavioral evaluation system in a
Chinese language version (NES-C) and a mood inventory of the profile of
mood states (POMS) were applied to assess the psychological effects of
low-level exposure to mercury vapor in a group of 88 workers (19 males
and 69 females, with mean age of 34.2 years) exposed to mercury vapor
(average duration of exposure 10.4 years). The well-matched group of 97
nonexposed workers was treated as the control. The intensity of current
mercury vapor was relatively mild as reflected by the average level of
mercury in the air of the workplace (0.033 mg/m3) and in urine (0.025
mg/liter). The results indicated that the profile of mood states posed
was moving to the negative side in Hg-exposed group and most of the
NES-C performances, in particular, the mental arithmetic, two-digit
search, switching attention, visual choice reaction time, and finger
tapping, were also significantly affected compared with those obtained
from controls (P < 0.05-0.01). The present study and the previous
study on the validation of the system suggest that the NES-C we
developed is valid for the neurotoxicity screening among the working
population exposed to neurotoxic agents.
PMID: 8472661
41. Blood-brain barrier flux of aluminum, manganese, iron and other
metals suspected to contribute to metal-induced neurodegeneration
Yokel RA.
J Alzheimers Dis. 2006 Nov;10(2-3):223-53.
The etiology of many neurodegenerative diseases has been only
partly attributed to acquired traits, suggesting environmental factors
may also contribute. Metal dyshomeostasis causes or has been implicated
in many neurodegenerative diseases. Metal flux across the blood-brain
barrier (the primary route of brain metal uptake) and the choroid
plexuses as well as sensory nerve metal uptake from the nasal cavity
are reviewed. Transporters that have been described at the blood-brain
barrier are listed to illustrate the extensive possibilities for moving
substances into and out of the brain. The controversial role of
aluminum in Alzheimer's disease, evidence suggesting brain aluminum
uptake by transferrin-receptor mediated endocytosis and of aluminum
citrate by system Xc;{-} and an organic anion transporter, and results
suggesting transporter-mediated aluminum brain efflux are reviewed. The
ability of manganese to produce a parkinsonism-like syndrome, evidence
suggesting manganese uptake by transferrin- and
non-transferrin-dependent mechanisms which may include store-operated
calcium channels, and the lack of transporter-mediated manganese brain
efflux, are discussed. The evidence for transferrin-dependent and
independent mechanisms of brain iron uptake is presented. The copper
transporters, ATP7A and ATP7B, and their roles in Menkes and Wilson's
diseases, are summarized. Brain zinc uptake is facilitated by L- and
D-histidine, but a transporter, if involved, has not been identified.
Brain lead uptake may involve a non-energy-dependent process,
store-operated calcium channels, and/or an ATP-dependent calcium pump.
Methyl mercury can form a complex with L-cysteine that mimics
methionine, enabling its transport by the L system. The putative roles
of zinc transporters, ZnT and Zip, in regulating brain zinc are
discussed. Although brain uptake mechanisms for some metals have been
identified, metal efflux from the brain has received little attention,
preventing integration of all processes that contribute to brain metal
concentrations.
PMID: 17119290
42. Inorganics and hormesis
Calabrese EJ, Baldwin LA.
Crit Rev Toxicol. 2003;33(3-4):215-304.
The article is a comprehensive review of the occurrence of hormetic
dose-response relationships induced by inorganic agents, including
toxic agents, of significant environmental and public health interest
(e.g., arsenic, cadmium, lead, mercury, selenium, and zinc). Hormetic
responses occurred in a wide range of biological models (i.e., plants,
invertebrate and vertebrate animals) for a large and diverse array of
endpoints. Particular attention was given to providing an assessment of
the quantitative features of the dose-response relationships and
underlying mechanisms that could account for the biphasic nature of the
hormetic response. These findings indicate that hormetic responses
commonly occur in appropriately designed experiments and are highly
generalizeable with respect to biological model responses. The hormetic
dose response should be seen as a reliable feature of the dose response
for inorganic agents and will have an important impact on the estimated
effects of such agents on environmental and human receptors.
PMID: 12809427
43. Methods and rationale for derivation of a reference dose for
methylmercury by the U.S. EPA
Rice DC, Schoeny R, Mahaffey K.
Risk Anal. 2003 Feb;23(1):107-15.
In 2001, the U.S. Environmental Protection Agency derived a
reference dose (RfD) for methylmercury, which is a daily intake that is
likely to be without appreciable risk of deleterious effects during a
lifetime. This derivation used a series of benchmark dose (BMD)
analyses provided by a National Research Council (NRC) panel convened
to assess the health effects of methylmercury. Analyses were performed
for a number of endpoints from three large longitudinal cohort studies
of the neuropsychological consequences of in utero exposure to
methylmercury: the Faroe Islands, Seychelles Islands, and New Zealand
studies. Adverse effects were identified in the Faroe Islands and New
Zealand studies, but not in the Seychelles Islands. The NRC also
performed an integrative analysis of all three studies. The EPA applied
a total uncertainty factor (UF) of 10 for intrahuman toxicokinetic and
toxicodynamic variability and uncertainty. Dose conversion from cord
blood mercury concentrations to maternal methylmercury intake was
performed using a one-compartment model. Derivation of potential RfDs
from a number of endpoints from the Faroe Islands study converged on
0.1 microg/kg/day, as did the integrative analysis of all three
studies. EPA identified several areas for which further information or
analyses is needed. Perhaps the most immediately relevant is the ratio
of cord:maternal blood mercury concentration, as well as the
variability around this ratio. EPA assumed in its dose conversion that
the ratio was 1.0; however, available data suggest it is perhaps
1.5-2.0. Verification of a deviation from unity presumably would be
translated directly into comparable reduction in the RfD. Other areas
that EPA identified as significant areas requiring further attention
are cardiovascular consequences of methylmercury exposure and delayed
neurotoxicity during aging as a result of previous developmental or
adult exposure.
PMID: 12635727
44. Methylmercury alters glutamate transport in astrocytes
Aschner M, Yao CP, Allen JW, Tan KH.
Neurochem Int. 2000 Aug-Sep;37(2-3):199-206.
Methylmercury (MeHg) is a significant environmental contaminant
that will continue to pose great risk to human health. Considerable
attention in the scientific and health policy fora is focused on the
question of whether MeHg intake from a diet high in fish is associated
with aberrant CNS function. A number of recent studies (Kjellstrom et
al., 1986: Kjellstrom, T., Kennedy, P., Wallis, S., Mantell, C., 1986.
Physical and mental development of children with prenatal exposure to
mercury from fish. Stage I: preliminary tests at age 4. Solna, Sweden.
National Swedish Environmental Protection Board Report 3080, 1989:
Kjellstrom, T., Kennedy, P., Wallis, S., Stewart, A., Friberg, L. et
al., 1989. Physical and mental development of children with prenatal
exposure to mercury from fish. Stage II: interviews and psychological
tests at age 6. Solna, Sweden. National Swedish Environmental
Protection Board Report 3642; McKeown-Eyssen et al., 1983:
McKeown-Eyssen, G., Ruedy, J., Neims, A. , 1983. Methylmercury exposure
in Northern Quebec II: neurologic findings in children. American
Journal of Epidemiology 118, 470-479; Grandjean et al., 1997:
Grandjean, P., Weihe, P., White, R. F., Debes, F., Araki, S., Yokoyama,
K., Murata, K., Sorensen, N., Dahl, R., Jorgensen, P. J., 1997.
Cognitive deficit in 7-year-old children with prenatal exposure to
methylmercury. Neurotoxicology and Teratology 19, 417-428) suggest that
fetal exposure at levels attained by mothers eating fish regularly
during pregnancy are associated with neurological deficits in their
offspring. Astrocytes play a key role in MeHg-induced excitotoxicity.
(1) MeHg preferentially accumulates in astrocytes. (2) MeHg potently
and specifically inhibits glutamate uptake in astrocytes. (3) Neuronal
dysfunction is secondary to disturbances in astrocytes. (4)
Co-application of nontoxic concentrations of MeHg and glutamate leads
to the typical appearance of neuronal lesions associated with
excitotoxic stimulation. (5) MeHg induces swelling of astrocytes. These
observations are fully consistent with MeHg-induced dysregulation of
excitatory amino acid homeostasis, and indicate that a
glutamate-mediated excitotoxic mechanism is involved. This manuscript
details the role of astrocytes in mediating MeHg-induced
excitotoxicity, and elaborates on the protective role afforded by
metallothioneins (MTs) in attenuating MeHg cytotoxicity.
PMID: 10812205
45. Exposure, metabolism, and toxicity of rare earths and related
compounds
Hirano S, Suzuki KT.
Environ Health Perspect. 1996 Mar;104 Suppl 1:85-95.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1469566&blobtype=pdf
For the past three decades, most attention in heavy metal
toxicology has been paid to cadmium, mercury, lead, chromium, nickel,
vanadium, and tin because these metals widely polluted the environment.
However, with the development of new materials in the last decade, the
need for toxicological studies on those new materials has been
increasing. A group of rare earths (RE) is a good example. Although
some RE have been used for superconductors, plastic magnets, and
ceramics, few toxicological data are available compared to other heavy
metals described above. Because chemical properties of RE are very
similar, it is plausible that their binding affinities to biomolecules,
metabolism, and toxicity in the living system are also very similar. In
this report, we present an overview of the metabolism and health
hazards of RE and related compounds, including our recent studies.
PMID: 8722113
46. Exposure to toxic elements via breast milk
Oskarsson A, Palminger Hallén I, Sundberg J.
Analyst. 1995 Mar;120(3):765-70.
Breast milk is the ideal nutrient for the newborn, but
unfortunately also a route of excretion for some toxic substances. Very
little attention has been paid to breast milk as a source of exposure
to toxic elements. The dose-dependent excretion is breast milk and the
uptake in the neonate of inorganic mercury, methylmercury and lead were
studied in an experimental model for rats and mice. The transfer of
mercury from plasma to milk was found to be higher in dams exposed to
inorganic mercury than to methylmercury. In contrast, the uptake of
mercury from milk was higher in the sucklings of dams exposed to
methylmercury than to inorganic mercury. Pre- and postnatal exposure to
methylmercury resulted in increased numbers and altered proportions of
the thymocyte subpopulation and increased lymphocyte activities in the
offspring of mice and also effects on the levels of noradrenaline and
nerve growth factor in the developing brain of rats. Mercury in blood
and breast milk in lactating women in Sweden was studied in relation to
the exposure to mercury from, fish and amalgam. Low levels were found;
the mean levels were 0.6 ng g-1 in milk and 2.3 ng g-1 in blood. There
was a statistically significant correlation between mercury levels in
blood and milk, showing that milk levels were approximately 30% of the
levels in blood. Inorganic mercury exposure from amalgam was reflected
in blood and milk mercury levels. Recent exposure to methylmercury from
consumption of fish was reflected in mercury levels in the blood but
not in milk.(ABSTRACT TRUNCATED AT 250 WORDS)
PMID: 7741226
47. An analysis of autopsy brain tissue from infants prenatally exposed
to methymercury
Lapham LW et al.
Neurotoxicology. 1995 Winter;16(4):689-704.
Brains from 32 neonatal autopsies from the Seychelles were examined
histologically and analyzed for mercury levels. Six brain regions were
sampled: frontal and occipital cortex, temporal cortex with
hippocampus, basal ganglia with thalamus, cerebellum, and pons with
medulla. Tissue blocks for histology and mercury analysis were taken
from opposing faces to provide for correlation of findings. Similar
studies were performed on 12 reference neonatal brains from Rochester,
New York. No clear-cut developmental abnormality was found, but some
brains exhibited low-grade, non-specific destructive changes. Total
mercury levels, most of it in the organic form, were elevated in many
of the Seychelles specimens. No correlation was demonstrated between
mercury levels and degree or type of histologic change. There was
considerable variability in total mercury for each anatomic region
among the 32 Seychelles cases, as well as from one region to another in
individual brains. All values of total mercury were under 300 ppb.
Statistical analysis of mean mercury levels for each region
demonstrated higher values in deep subcortical nuclei, brain stem, and
cerebellum, phylogenetically older parts of the brain. When total
mercury concentration of each region was paired with all other areas in
the same brain and the paired values plotted for the entire group of
brains, high correlations were obtained for all brain pairs, suggesting
a strong concentration-dependent relationship between mercury intake
and brain content. Analysis of mercury levels in separately dissected
blocks of grey and white matter from 12 specimens revealed no
significant differences between grey and white. In comparison with
other human developmental studies and with experimental developmental
studies in animals, where toxicity has been demonstrated with total
mercury brain levels above 1,000 ppb, this study found no evidence of
toxicity within a range of mercury levels below 300 ppb. Submicroscopic
changes, subcellular alterations, subtle disturbances in the unfolding
of brain architectonics -- none of these are excluded with methods used
in this report. Further studies of threshold effects of MeHg on fetal
brain are essential. That approximately half of the mercury resides in
glial elements in white matter reinforces the need to focus attention
upon glia as well as neurons during development.
PMID: 8714873
48. Principles of developmental neurotoxicology
Slikker W Jr.
Neurotoxicology. 1994 Spring;15(1):11-6.
With 4-8 percent of U.S. children exhibiting anatomical and/or
functional deficits, and the occurrence of several tragic clinical
syndromes resulting from developmental exposure to such agents as
ethanol, lead and methylmercury, there is good reason to focus
attention on the principles of developmental neurotoxicology. Various
animal models have been used to confirm the developmental neurotoxicity
that results from exposure to these agents, and along with clinical
evidence, have implicated several other chemical classes such as
antimitotics, insecticides, polyhalogenated hydrocarbons, psychoactive
drugs, solvents and vitamins as specific agents with developmental
neurotoxic potential. As for developmental toxicity in general, the
nature and extent of neurotoxic effects are often dependent on the
timing of exposure, and because stages of nervous system development
can vary significantly between species in relation to the time of
birth, variations in neurotoxic outcome across species are expected.
There are several instances in which functional alterations (e.g.,
neuromotor development, locomotor activity, reactivity and/or
habituation, learning and memory and sensory system modulation) have
been observed at doses below those needed to produce other indicators
of developmental toxicity. Neuroanatomical/neurohistological,
neurochemical and neurophysiological endpoints have been used to
substantiate these functional deficits and/or to describe adverse
nervous system effects in the absence of functional data. As knowledge
about the toxicological mechanisms underlying the expression of
developmental neurotoxicity is increased, the ability to conduct
quantitative risk assessments and protect human health will be enhanced.
PMID: 8090351
49. Side-effects: mercury contribution to body burden from dental
amalgam
Reinhardt JW.
Adv Dent Res. 1992 Sep;6:110-3.
http://adr.iadrjournals.org/cgi/reprint/6/1/110
The purpose of this paper is to examine and report on studies that
relate mercury levels in human tissues to the presence of dental
amalgams, giving special attention to autopsy studies. Until recently,
there have been few published studies examining the relationship
between dental amalgams and tissue mercury levels. Improved and highly
sensitive tissue analysis techniques have made it possible to measure
elements in the concentration range of parts per billion. The fact that
mercury can be absorbed and reach toxic levels in human tissues makes
any and all exposure to that element of scientific interest. Dental
amalgams have long been believed to be of little significance as
contributors to the overall body burden of mercury, because the
elemental form of mercury is rapidly consumed in the setting reaction
of the restoration. Studies showing measurable elemental mercury vapor
release from dental amalgams have raised renewed concern about amalgam
safety. Mercury vapor absorption occurs through the lungs, with about
80% of the inhaled vapor being absorbed by the lungs and rapidly
entering the bloodstream. Following distribution by blood circulation,
mercury can enter and remain in certain tissues for longer periods of
time, since the half-life of excretion is prolonged. Two of the primary
target organs of concern are the central nervous system and kidneys.
PMID: 1292449
50. Immunotoxic effects of mercuric compounds on human lymphocytes and
monocytes. I. Suppression of T-cell activation
Shenker BJ, Rooney C, Vitale L, Shapiro IM.
Immunopharmacol Immunotoxicol. 1992;14(3):539-53.
Considerable attention has been directed at defining the health
deficits associated with exposure to mercurial compounds. While
numerous studies have been conducted, the findings have been somewhat
contradictory and have led to a confused understanding of the
immunotoxicology of mercury. It is becoming clear, however, that the
immunotoxic effects of heavy metals in general, and mercury in
particular, are dependent upon the assays and source of cells. The
major goal of our study was to assess whether low level mercury
exposure modulates human T-cell function. Following treatment of
T-cells with HgCl2 (0-1000 ng) and MeHgCl (0-100 ng), their activation
by mitogens was evaluated. Both forms of mercury caused a dose
dependent reduction in T cell proliferation, however, the effect was
dependent upon the presence of monocytes. Moreover, in the absence of
monocytes, HgCl2 enhance PMA induced T-cell proliferation. MeHgCl was
approximately 5-10 times more potent than HgCl2. Mercury also inhibited
the ability of these cells to synthesize and secrete IL-1. Analysis of
the expression of activation markers on the cell surface indicated that
one of the earliest markers of lymphocyte activation, CD69, was not
effected by mercury. In comparison, T-cell expression of IL-2R and the
transferrin receptor was impaired. Of particular interest, cells
activated by mitogen for 24 hr became refractory to the immunotoxic
effects of mercury. The results of this investigation clearly show that
mercury-containing compounds are immunomodulatory; moreover, the
decrease in T-cell function following exposure to mercury indicates
that this metal is immunotoxic at very low exposure levels.
PMID: 1517533
51. The health effects of aluminium--a review
Cooke K, Gould MH.
J R Soc Health. 1991 Oct;111(5):163-8.
This review covers the occurrence of aluminium in soil, air, water and
food. In addition, aluminium levels in body tissues and its movement
within the body have been considered. The adverse effects of aluminium
that have been reported in recent years include Alzheimer's disease,
dementia and hyperactivity and learning disorders in children.
PMID: 1795349
52. Vaccine ingredients & schedule
http://www.generationrescue.org/pdf/080212.pdf
Additional topics will be added from time to time
Return to ADHD Table of Contents
|
|